Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis.
about
Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivoIn vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazoleEfficacy of nikkomycin Z in the treatment of murine histoplasmosisAntifungal peptides: novel therapeutic compounds against emerging pathogensMolecular characterization of two genes from Streptomyces tendae Tü901 required for the formation of the 4-formyl-4-imidazolin-2-one-containing nucleoside moiety of the peptidyl nucleoside antibiotic nikkomycinRecent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosisStructure and function of sawB, a gene involved in differentiation of Streptomyces ansochromogenes.Cloning, sequencing and function of sanA, a gene involved in nikkomycin biosynthesis of Streptomyces ansochromogenes.In vitro efficacy of nikkomycin Z against the human isolate of the microsporidian species Encephalitozoon hellem.CoccidioidomycosisSupramolecular hydrogels made of basic biological building blocks.Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.Peptide-based Antifungal Therapies against Emerging Infections.Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model.Antifungal peptides: potential candidates for the treatment of fungal infections.New investigational antifungal agents for treating invasive fungal infections.The public health impact of coccidioidomycosis in Arizona and California.Investigational antifungal agents.Chitin biosynthesis in Candida albicans grown in vitro and in vivo and its inhibition by nikkomycin Z.Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.A practical and scalable manufacturing process for an anti-fungal agent, Nikkomycin Z.Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiaeNucleobase-containing peptides: an overview of their characteristic features and applications.Treatment of endemic mycoses.Regulation of expression, activity and localization of fungal chitin synthases.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Characterization of a dual specificity aryl acid adenylation enzyme with dual function in nikkomycin biosynthesis.Natural and engineered biosynthesis of nucleoside antibiotics in Actinomycetes.A review on comparative mechanistic studies of antimicrobial peptides against archaea.Systemic Antifungal Agents: Current Status and Projected Future Developments.Antifungal therapeutics for dimorphic fungal pathogens.The antifungal pipeline: a reality check.Efficacy of nikkomycin Z against experimental pulmonary blastomycosis.Drugs in Clinical Development for Fungal Infections.Supramolecular nanofibers and hydrogels of nucleopeptides.Compounds active against cell walls of medically important fungiEvaluation of the susceptibility of Coccidioides immitis to lufenuron, a chitin synthase inhibitor.Pharmacokinetics of nikkomycin Z after single rising oral dosesAntihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.
P2860
Q28316948-C8863B97-8055-43FD-9126-60DE46377B95Q28343353-76916A2A-EE80-41F5-8511-9F8E3136D7BAQ28368902-1EEB889E-34E1-4D80-87D6-01A1B0DD8662Q28369443-3F6DD83A-533D-47E9-BD78-8223E6D82CDFQ28372954-DEC01AD6-FA14-4201-BC5F-62EEB65F2793Q28675835-AF15AC90-7ECA-4E47-AF02-81BD22BD56ADQ33363225-6C07C1B6-3D78-4124-8446-F4C585E6C5CAQ33365546-8AE8C3A4-C0C3-4CC8-9948-AA145E8E4F7FQ33594001-9E2F2429-59B6-455C-972B-CA35AE6160E7Q33607145-4B382B9C-21BA-4A78-BBCD-A2BB7980110CQ33625101-99FBE96E-CA27-4D8F-A43A-B1B4753E1777Q33684393-82E7143B-E08E-4BAA-A42B-12B5FC861E4EQ33862289-ABE3FC93-714B-4580-AC2F-16ACE665D63DQ33976048-489F5FC8-7511-47AE-BF41-9E860B98C93DQ33979766-94449F61-A339-43BB-B1D1-0FB75372F7D7Q34074702-10FF6C74-E289-4D67-963A-36DF268AD470Q34075014-01725FA4-1615-4429-A6EB-7D797164E58DQ34194528-B28A5AF6-745B-4888-815D-2B4F55482E8FQ34335243-2EF8FC78-CDE8-4D22-BB8F-81EC36FA7427Q35897040-B1298BD3-DCAB-477D-AEA7-8C2C04DEA117Q36290706-59F16BA6-3B40-495C-BDE8-FF3639F2C453Q36630610-1BE6F3C6-7A07-47BB-9B88-0407D985254AQ36697706-068867CE-609A-4623-B55D-459537447AA4Q37720533-42CC0CED-6771-40BE-8985-813FE92EFA99Q37729998-83B4A348-A1EC-4EDD-A5F3-D9127C616493Q37869907-5ADF5994-3126-4468-B025-5821CF0BB0B4Q37918556-64E0C07E-06B1-44E5-95AC-1B72F5F3E0F8Q38484081-788F98D1-E965-422C-B914-9026EFD9E328Q38543806-FC32CA3B-F33A-461C-836C-13FA352D2F30Q38653377-C8BF23F1-C6B1-4E6A-A3E3-6B45F56D4CC1Q38796140-7FF63062-2B11-4B57-B90F-5897C20504D3Q38959083-FD8F8D0F-0C17-4E73-AF75-15A318059690Q39299949-5F5CBB7C-A583-4BA4-BA5C-6A566466F20AQ39784951-E2E91435-C3CE-4206-810F-B3FFB914F1CCQ40070714-9257DEBE-FC5B-420F-9068-66D6917A9036Q40156299-927EF2A8-DAB3-454D-A15C-FCF1F5AA862BQ40889532-C33094E0-8830-42AF-B21C-AFF385DFC570Q41715996-854A1962-2A1B-49BE-9345-E405C618F140Q41827850-656FD9C3-5F26-43D9-BCC4-7822ADFF8E28Q42538961-F7B5E9AE-C7C0-4C54-A6CB-0B98A3E2A052
P2860
Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@ast
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@en
type
label
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@ast
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@en
prefLabel
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@ast
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@en
P2093
P2860
P356
P1476
Evaluation of nikkomycins X an ...... oplasmosis, and blastomycosis.
@en
P2093
Pappagianis D
P2860
P304
P356
10.1128/AAC.34.4.587
P407
P577
1990-04-01T00:00:00Z